国际皮肤性病学杂志    2002 28 (3): 162-166   ISSN: 2096-5540  CN: 32-1880/R   DNA酶Ⅰ缺陷与SLE相关性的研究进展 王展, 曾凡钦 中山医科大学孙逸仙纪念医院皮肤科 广州 510120 收稿日期 2001-10-11  修回日期 null  网络版发布日期 null 参考文献  [1] Berden JH,Licht R,van Bruggen MC,et al.Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis.Curt Opin Nephrol Hypertens,1999,8(3):299-306. [2] Lacks SA.Deoxyribonuclease Ⅰ in mammalian tissues.Specificity of inhi-bition by actin.J Biol Chem,1981,256(6):2644-2648. [3] Chitrabammng S,Rubin RL,Tan EM.Serum deoxyribonuclease Ⅰ and clinical activity in systemic lupus erythematosus.Rheumatol Int,1981,1(2):55-60. [4] Macanovic M,Lachmann PJ.Measurement of deoxyribonuclease Ⅰ(DNase) in the serum and urine of systemic lupus erythematesus(SLE)-prone NZB/NZW mice by a new radial enzyme diffusian assay.Clin Exp Immunol,1997,108(2):220-226. [5] Lefkowith JB,Kiehl M,Rttbenstein J,et al.Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus.J Clin Invest,1996,98(6):1373-1380. [6] TerRorg EJ,Horst G,Hummel EJ,et al.Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus.A lang-term,prospective study.Arthritis Rheum,1990,33(5):634-643. [7] Malide D,Londono I,Russo P,et al.Ultrastructttral localization of DNA in immune deposits of human lupus nephritis.Am J Pathol,1993,143(1):304-311. [8] Macanovic M,Sinicrepi D,Shak S,et al.The treatment of systemic lupus erythematesus(SLE) in NZB/WF1 hybrid mice; studies with recombi-nant murine DNase and with dexamethesone.Clin Exp Immunol,1996,106(2):243-252. [9] Walport MJ.Lupus,DNase and defective disposal of cellular debris.Nat Genet,2000,25(2):135-136. [10] Rumore PM,Steinman CR.Endogenous circulating DNA in systemic lu-pus erythematesus.Occurrence as multimeric complexes bound to histone.J Clin Invest,1990,86(1):69-74. [11] Mohan C,Adams S,Stanik V,et al.Nucleosome:a major immunogen for pathogenic autoantibody-inducing T cells of lupus.J Exp Med,1993,177(5):1367-1381. [12] Botto M,Dell' Agnola C,Bygrave AE,et al.Homozygous Clq deficiency causes glomemlonephritis associated with multiple apeptotic bodies.Nat Genet,1998,19(1):56-59. [13] Bickerstaff MC,Botto M,Hutehinsan WL,et al.Serum amyloid P component controls chromatin degradation and prevents antinuclear antoimmunity.Nat Med,1999,5(6):694-697. [14] Polzar B,Zanotti S,Stephan H,et al.Distributien of dooxyribonuclease Ⅰ in rat tissues and its correlation to cellular turnover and apoptosis(programmed cell death).Eur J Cell Biol,1994,64(1):200-210. [15] Lachmann PJ.The in vivo destructien of antigen-a tool for probing and modulating an autoimmune response.CAin Exp Immunol,1996,106(2):187-189. [16] Peitsch MC,Innler M,French LE,et al.Genomic organisatien and expressien of mouse deoxyribonuclease Ⅰ.Bioohern Biophys Res Commun,1995,207(1):62-68. [17] Napirei M,Karsunky H,Zevnik B,et al.Features of systemic lupus erythematosus in Dnasel-deficient mice.Nat Genet,2000,25(2):177-181. [18] Lazarides E,Lindberg U.Actin is the naturally occurring inhibitor of deoxyribonuclease I.Prec Nail Acad Sci U S A,1974,71(12):4742-4746. [19] Hadjiyannaki K,Lachmann PJ.The relation of deoxyribenuclease inhibitor levels to the occurrence of antinuclear antibodies in NZB-NZW mice.Clin Exp lmmunol,1972,11(2):291-295. [20] Ulmer JS,Herzka A,Toy KJ,et al.Engineering actin-resistsnt human DNase Ⅰ for treatment of cystic frbrosis.Proc Natl Acad Sci U S A,1996,93(16):8225-8229. [21] Puccetti A,Madaio MP,Bellese G,et al.Anti-DNA antibodies bind to DNase Ⅰ.J Exp Med,1995,181(5):1797-1804. [22] Shak S,Capon DJ,Hellmiss R,et al.Recombinant human DNase Ⅰ reduces the viscosity of cystic fibrosis sputum.Proc Natl Acad Sci U S A,1990,87(23):9188-9192. [23] Davis JC Jr,Manzi S,Yarboro C,et al.Recombinant human ⅠDnase Ⅰ(rhDNase) in patients with lupus nephritis.Lupus,1999,8(1):68-76. [24] Prince WS,Baker DL,Dodge AH,et al.Pharmacodynamics of recombinant human DNase Ⅰ in serum.Clin Exp Immunol,1998,113(2):289. [25] Pan CQ,Dodge TH,Baker DL,et al.Improved potency of hyperactive and actin-resistant human DNase Ⅰ variants for treatment of cystic fibrosis and systemic lupus erythematosus.J Biol Chem,1998,273(29):18374. 通讯作者: